Background. Multiple endocrine neoplasia (MEN) type 1 is accompanied b
y adrenal involvement, but characteristics and clinical handling of th
is lesion have been insufficiently explored. Methods. Patients with ME
N 1 (n = 43) were monitored (mean, 6.3 years) with annual biochemical
and radiologic adrenal evaluation. Adrenal specimens were examined by
in situ RNA-RNA hybridization for expression of the MEN 1 candidate ge
ne phospholipase C beta 3 (PLC beta 3) and immunostaining for insulin-
like growth factor-1 receptor. Results. Altogether 17 patients (40%) d
isplayed adrenal enlargement, which was limited to the adrenal cortex
and showed signs of progression, marked atypia, and cancer development
in three of them. Only the carcinoma exhibited adrenocortical hormone
excess. PLC beta 3 was expressed in the hyperplastic and adenomatous
proliferation but not the carcinoma. Pancreatic endocrine tumors with
insulin-proinsulin excess were overrepresented in the patients with ad
renocortical involvement, but significant insulin-like growth factor-1
receptor immunoreactivity was restricted to the carcinoma. Conclusion
s. The prevalent adrenocortical lesion associated with MEN 1 requires
regular attention because of malignant potential. It was unrelated to
loss of constitution heterozygosity for the MEN 1 locus (11q13) and PL
C beta 3 expression, except for the cortical carcinoma exhibiting alle
lic losses involving also the Wiedemann-Beckwith gene at 11p15. Mechan
isms for mitogenic relationships between the pancreatic and adrenal le
sions of MEN 1 demand further clarification.